Nuoning Biology
Latest round
- Series A
Last raised
- Oct 2018
Total raised
- $7.2M
Investors
- 2
About Nuoning Biology
Based in Beijing, China and established in 2015, Biology is a biotechnology company that focuses on research and developing polymer antibody-drug conjugate (ADC).,Ltd. The company engages in research and development of polymer antibody-drug conjugate. Nuoning Biology focuses on the research and development of antibody-drug conjugates (ADCs), master's the world's only polymer conjugation technology and third-generation ADC technology and develops multiple ADC products based on core technologies with independent intellectual property rights. The company's products are suitable for diseases such as lung cancer, breast cancer, cervical cancer, ovarian cancer, and prostate cancer, etc. The company’s revenue is generated by selling polymer antibody-drug conjugate to customers. In the future, the company will develop ADC products for different cancers.
Who invested in Nuoning Biology
2 investors across 1 round
See all investors in Nuoning Biology
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Oct 31, 2018
Amount
$7.2M
Investors
Questions about Nuoning Biology
Who invested in Nuoning Biology?
Nuoning Biology has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Nuoning Biology raised?
Nuoning Biology has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Nuoning Biology last raise money?
Nuoning Biology's most recent round on record is a Series A, in Oct 2018.
What does Nuoning Biology do?
Based in Beijing, China and established in 2015, Biology is a biotechnology company that focuses on research and developing polymer antibody-drug conjugate (ADC).
Where is Nuoning Biology headquartered?
Nuoning Biology is headquartered in Beijing, China.
Which VCs invest in companies like Nuoning Biology?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Nuoning Biology's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Nuoning Biology? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.